Substance

ID:560

Names and Identifiers
IUPAC name
bis(propan-2-yl) fluorophosphonate
IUPAC Traditional name
isoflurophate
Synonyms
DFPDiflupylDiflurophateIsoflurophateDiisopropoxyphosphoryl Fluoride
Brand Name
Diisopropyl FluorophosphateDiisopropyl PhosphofluoridateFloroprylIsoflurophosphateIsopropyl FluophosphateNeoglaucitDyflosHumorsolIsopropyl PhosphorofluoridateDisiopropyl FluorophosphonateIsofluorphatePF-3DiisopropylfluorfosfatFluroprylIsofluorophateO,O-Diisopropyl FluorophosphateDiisopropyl FluoridophosphateDiisopropyl FluorophosphonateDiisopropyl PhosphorofluoridateFluorodiisopropyl PhosphateFluoroprylFluostigmine
Registration numbers
PubChem CID
PubChem SID
CAS Number
Properties
Physical Property
Solubility
1.54E+004 mg/L
Hydrophobicity(logP)
1.4
Molecule Details
Drug Groups
approved
Description
An irreversible cholinesterase inhibitor with actions similar to those of echothiophate. It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically. (From Martindale, The Extra Pharmacopoeia, 29th ed, p1330)
Indication
For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.
Pharmacology
Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.
Toxicity
Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.
Affected Organisms
Humans and other mammals
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data